We've found
6,982
archived clinical trials in
Endocrine
We've found
6,982
archived clinical trials in
Endocrine
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Updated: 12/31/1969
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Improvement of Insulin Resistance After Bariatric Surgery
Updated: 12/31/1969
Mechanisms Underlying the Improvement of Insulin Resistance in Response to Bariatric Surgery
Status: Enrolling
Updated: 12/31/1969
Improvement of Insulin Resistance After Bariatric Surgery
Updated: 12/31/1969
Mechanisms Underlying the Improvement of Insulin Resistance in Response to Bariatric Surgery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy
Updated: 12/31/1969
Prospective, Open-Label, Randomized, Controlled, Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy Using Dosage Recommending Device
Status: Enrolling
Updated: 12/31/1969
Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy
Updated: 12/31/1969
Prospective, Open-Label, Randomized, Controlled, Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy Using Dosage Recommending Device
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia
Updated: 12/31/1969
The Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia
Status: Enrolling
Updated: 12/31/1969
The Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia
Updated: 12/31/1969
The Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Updated: 12/31/1969
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Status: Enrolling
Updated: 12/31/1969
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Updated: 12/31/1969
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Updated: 12/31/1969
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Status: Enrolling
Updated: 12/31/1969
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Updated: 12/31/1969
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Updated: 12/31/1969
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Updated: 12/31/1969
A Multicenter, Open-Label, Dose Escalating Study of the Safety, Tolerability and Pharmacology of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Updated: 12/31/1969
A Multicenter, Open-Label, Dose Escalating Study of the Safety, Tolerability and Pharmacology of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Updated: 12/31/1969
A Multicenter, Open-Label, Dose Escalating Study of the Safety, Tolerability and Pharmacology of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Updated: 12/31/1969
A Multicenter, Open-Label, Dose Escalating Study of the Safety, Tolerability and Pharmacology of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Updated: 12/31/1969
A Multicenter, Open-Label, Dose Escalating Study of the Safety, Tolerability and Pharmacology of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Updated: 12/31/1969
A Multicenter, Open-Label, Dose Escalating Study of the Safety, Tolerability and Pharmacology of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of Asfotase Alfa in Adolescents and Adults With Hypophosphatasia (HPP)
Updated: 12/31/1969
A Randomized, Open-Label, Multicenter, Multinational, Dose-Ranging, Concurrent Control Study of the Safety, Efficacy, Pharmacokinetic of ENB-0040 (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Adolescents and Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of Asfotase Alfa in Adolescents and Adults With Hypophosphatasia (HPP)
Updated: 12/31/1969
A Randomized, Open-Label, Multicenter, Multinational, Dose-Ranging, Concurrent Control Study of the Safety, Efficacy, Pharmacokinetic of ENB-0040 (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Adolescents and Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of Asfotase Alfa in Adolescents and Adults With Hypophosphatasia (HPP)
Updated: 12/31/1969
A Randomized, Open-Label, Multicenter, Multinational, Dose-Ranging, Concurrent Control Study of the Safety, Efficacy, Pharmacokinetic of ENB-0040 (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Adolescents and Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of Asfotase Alfa in Adolescents and Adults With Hypophosphatasia (HPP)
Updated: 12/31/1969
A Randomized, Open-Label, Multicenter, Multinational, Dose-Ranging, Concurrent Control Study of the Safety, Efficacy, Pharmacokinetic of ENB-0040 (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Adolescents and Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of Asfotase Alfa in Adolescents and Adults With Hypophosphatasia (HPP)
Updated: 12/31/1969
A Randomized, Open-Label, Multicenter, Multinational, Dose-Ranging, Concurrent Control Study of the Safety, Efficacy, Pharmacokinetic of ENB-0040 (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Adolescents and Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of Asfotase Alfa in Adolescents and Adults With Hypophosphatasia (HPP)
Updated: 12/31/1969
A Randomized, Open-Label, Multicenter, Multinational, Dose-Ranging, Concurrent Control Study of the Safety, Efficacy, Pharmacokinetic of ENB-0040 (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Adolescents and Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Real Time Myocardial Contrast Echocardiography and Dobutamine Stress Perfusion Magnetic Resonance Imaging
Updated: 12/31/1969
Quantification of Ventricular Mechanics/Myocardial Blood Flow Reserve in Adolescents and Adults Ages 12-50 With Congenital or Acquired Heart Disease Using Bicycle Stress With Real Time Myocardial Contrast Echo and Dobutamine Stress MRI
Status: Enrolling
Updated: 12/31/1969
Real Time Myocardial Contrast Echocardiography and Dobutamine Stress Perfusion Magnetic Resonance Imaging
Updated: 12/31/1969
Quantification of Ventricular Mechanics/Myocardial Blood Flow Reserve in Adolescents and Adults Ages 12-50 With Congenital or Acquired Heart Disease Using Bicycle Stress With Real Time Myocardial Contrast Echo and Dobutamine Stress MRI
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Asfotase Alfa in Juvenile Patients With Hypophosphatasia (HPP)
Updated: 12/31/1969
A Randomized, Open-Label, Multicenter, Multinational, Dose-Ranging, Historical Control Study of the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of ENB-0040 (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Children With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Asfotase Alfa in Juvenile Patients With Hypophosphatasia (HPP)
Updated: 12/31/1969
A Randomized, Open-Label, Multicenter, Multinational, Dose-Ranging, Historical Control Study of the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of ENB-0040 (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Children With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Asfotase Alfa in Juvenile Patients With Hypophosphatasia (HPP)
Updated: 12/31/1969
A Randomized, Open-Label, Multicenter, Multinational, Dose-Ranging, Historical Control Study of the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of ENB-0040 (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Children With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Asfotase Alfa in Juvenile Patients With Hypophosphatasia (HPP)
Updated: 12/31/1969
A Randomized, Open-Label, Multicenter, Multinational, Dose-Ranging, Historical Control Study of the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of ENB-0040 (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Children With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Incidence and Treatment of Insulin Resistance Among Men With Erectile Dysfunction
Updated: 1/31/2006
The Incidence and Treatment of Insulin Resistance Among Men With Erectile
Status: Enrolling
Updated: 1/31/2006
The Incidence and Treatment of Insulin Resistance Among Men With Erectile Dysfunction
Updated: 1/31/2006
The Incidence and Treatment of Insulin Resistance Among Men With Erectile
Status: Enrolling
Updated: 1/31/2006
Click here to add this to my saved trials
Does Testosterone Improve Function in Hypogonadal Older Men
Updated: 3/20/2006
Does Testosterone Improve Function in Hypogonadal Older Men
Status: Enrolling
Updated: 3/20/2006
Does Testosterone Improve Function in Hypogonadal Older Men
Updated: 3/20/2006
Does Testosterone Improve Function in Hypogonadal Older Men
Status: Enrolling
Updated: 3/20/2006
Click here to add this to my saved trials
The Effect of Thyroid Hormone Levels in Pregnant Women on the Intelligence Quotient (IQ) of Their Children
Updated: 3/30/2006
Are IQs Low in Offspring of Euthyroid Women With Low T4?
Status: Enrolling
Updated: 3/30/2006
The Effect of Thyroid Hormone Levels in Pregnant Women on the Intelligence Quotient (IQ) of Their Children
Updated: 3/30/2006
Are IQs Low in Offspring of Euthyroid Women With Low T4?
Status: Enrolling
Updated: 3/30/2006
Click here to add this to my saved trials
Treatment Targets for Chronic Hypertension in Pregnancy
Updated: 4/26/2006
Treatment Targets for Chronic Hypertension in Pregnancy
Status: Enrolling
Updated: 4/26/2006
Treatment Targets for Chronic Hypertension in Pregnancy
Updated: 4/26/2006
Treatment Targets for Chronic Hypertension in Pregnancy
Status: Enrolling
Updated: 4/26/2006
Click here to add this to my saved trials
Blood Sugars in Children With Idiopathic Seizures.
Updated: 9/6/2006
Prevalence of Hypoglycemia and/or Hyperinsulinism/Hyperammonemia Syndrome in Patients With Idiopathic Seizures.
Status: Enrolling
Updated: 9/6/2006
Blood Sugars in Children With Idiopathic Seizures.
Updated: 9/6/2006
Prevalence of Hypoglycemia and/or Hyperinsulinism/Hyperammonemia Syndrome in Patients With Idiopathic Seizures.
Status: Enrolling
Updated: 9/6/2006
Click here to add this to my saved trials
Feasibility of Radiofrequency Ablation in the Management of Papillary Thyroid Cancer Under Ultra-Sound Guidance.
Updated: 9/26/2006
Feasibility of Radio-Frequency Ablation in the Management of Papillary Thyroid Cancer Under Ultra-Sound Guidance
Status: Enrolling
Updated: 9/26/2006
Feasibility of Radiofrequency Ablation in the Management of Papillary Thyroid Cancer Under Ultra-Sound Guidance.
Updated: 9/26/2006
Feasibility of Radio-Frequency Ablation in the Management of Papillary Thyroid Cancer Under Ultra-Sound Guidance
Status: Enrolling
Updated: 9/26/2006
Click here to add this to my saved trials
Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-Treated Chronic Pain Patients: A Pilot Study.
Updated: 11/8/2006
Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-Treated Chronic Pain Patients: A Pilot Study.
Status: Enrolling
Updated: 11/8/2006
Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-Treated Chronic Pain Patients: A Pilot Study.
Updated: 11/8/2006
Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-Treated Chronic Pain Patients: A Pilot Study.
Status: Enrolling
Updated: 11/8/2006
Click here to add this to my saved trials
Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.
Updated: 12/1/2006
Comparison Fenofibrate, Rosiglitazone, or Weight Loss to Decrease Cardiovascular Risk in Insulin Resistant Dyslipidemic Individuals.
Status: Enrolling
Updated: 12/1/2006
Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.
Updated: 12/1/2006
Comparison Fenofibrate, Rosiglitazone, or Weight Loss to Decrease Cardiovascular Risk in Insulin Resistant Dyslipidemic Individuals.
Status: Enrolling
Updated: 12/1/2006
Click here to add this to my saved trials